Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
about
Hyperglycemia as a risk factor for cancer progressionNovel Endogenous, Insulin-Stimulated Akt2 Protein Interaction Partners in L6 MyoblastsIntegrating human omics data to prioritize candidate genesThe interactive role of type 2 diabetes mellitus and E-selectin S128R mutation on susceptibility to coronary heart disease.Obesity and cardio-metabolic risk factors in urban adults of Benin: relationship with socio-economic status, urbanisation, and lifestyle patterns.The metabolic syndromeLipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL.Role of SN1 lipases on plasma lipids in metabolic syndrome and obesityWaist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine.Abnormalities in circadian blood pressure variability and endothelial function: pragmatic markers for adverse cardiometabolic profiles in asymptomatic obese adults.Circadian rhythms, the molecular clock, and skeletal muscle.Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is the best surrogate marker for insulin resistance in non-obese Japanese adultsThe effects of treadmill exercise on expression of UCP-2 of brown adipose tissue and TNF-α of soleus muscle in obese Zucker ratsAssociation between serum C-peptide as a risk factor for cardiovascular disease and high-density lipoprotein cholesterol levels in nondiabetic individuals.Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults.Relationship between CYP17A1 genetic polymorphism and coronary artery disease in a Chinese Han population.Similar and additive effects of ovariectomy and diabetes on insulin resistance and lipid metabolismPeroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.Prevalence and clinical predictors of insulin resistance in reproductive-aged thai women with polycystic ovary syndrome.Protective role of oleic acid against cardiovascular insulin resistance and in the early and late cellular atherosclerotic process.Association of osteoprotegerin with impaired glucose regulation and microalbuminuria: the REACTION studyCardiovascular benefits of GLP-1-based herapies in patients with diabetes mellitus type 2: effects on endothelial and vascular dysfunction beyond glycemic control.Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up studyRelation of Cardiometabolic Risk Factors between Parents and Children.Impact of metabolic syndrome risk factors in first-degree relatives of type 2 diabetic patients.Serum 25(OH)D is inversely associated with metabolic syndrome risk profile among urban middle-aged Chinese populationMetabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF ratsInsulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instabilityAnthropometric and metabolic characteristics in children with clinically diagnosed nonalcoholic fatty liver disease.Prediabetes is associated with abnormal circadian blood pressure variabilityFeatured article: induction of heme oxygenase with hemin improves pericardial adipocyte morphology and function in obese Zucker rats by enhancing proteins of regeneration.Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: the GOCADAN study.Sleep and Glucose Intolerance/Diabetes MellitusGenetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome.Blood pressure reactions to insulin treatment in patients with type 2 diabetes.Effect of combination treatment of S-amlodipine with peroxisome proliferator-activated receptor agonists on metabolic and cardiovascular parameters in Zucker fa/fa rats.A Multifunctional Bread Rich in Beta Glucans and Low in Starch Improves Metabolic Control in Type 2 Diabetes: A Controlled Trial.The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized controlled trials.Effects of Extract from Solid-State Fermented Cordyceps sinensis on Type 2 Diabetes Mellitus.Pediatric non-high-density lipoprotein cholesterol, the metabolic syndrome, and insulin resistance
P2860
Q27687614-8DC7CBB1-68E4-4E2D-BC4D-2B8591B546AAQ28550274-4E73C1D2-FD5B-4F47-9083-81ECAA05C312Q28660898-EEDE66C4-09A2-44B4-9877-02632D30A836Q33288205-79A0B04A-E66C-4177-B3CD-360B989C16AAQ33322403-4E1C0482-0327-429C-94D0-EF4BD2F8F4A1Q33569142-65497714-E49F-4EB5-B0DA-A0E7A65A3792Q33719103-72EB76AA-9BF8-48A2-AE41-5FB9CB4D2C0EQ33925409-CA91E137-C07B-4EF0-8677-E7991CB0BF3DQ34054063-D2E126B0-B778-44D4-8941-E3FD5D1798CDQ34202997-67909B55-9DE6-458B-AB05-8E5132E5B843Q34454032-30FDBD3B-C712-4393-80E9-9319B3110A71Q34461822-B73FBA79-B727-4DD1-B7F6-0BCC563AA44AQ34563345-D1C13840-016E-481F-8C5C-55959127F2A9Q34822621-6897FD73-F106-4AF1-AD44-AD3073741BB8Q35054776-0874D85E-CAF9-4FB4-87F5-A14D5D3F3C0BQ35176614-53C4D43A-3165-4468-BB98-0F419995627DQ35193522-4CE7DAF4-8D02-473A-BF2D-757789AFF710Q35636191-43DEA79C-D645-48D8-B876-746CEE193319Q35687495-013EE9D5-8DC2-4FA5-B9C7-418060C73F43Q35763347-F0D67D15-5CBA-463E-9F6D-1D44561FE94BQ35857588-1982ACB0-71EA-449C-BB52-D2A22CEDB3E7Q35936644-CA5DE580-9A51-4459-A16C-6BCFE997A675Q36232060-0724AFC7-F6E0-43D5-908C-25D93CA7A23FQ36322466-C68D8990-2D09-4D56-B741-D5779FCEBCB0Q36325752-960B54A3-ECA5-4069-976B-DAEA5F2348CFQ36430558-373114D4-A5AC-4AA3-ABAD-2FFA6DBB262FQ36691127-747CF1D4-54BF-42D4-8013-6FDC22CA3DEDQ36741853-94E11285-C9D4-4164-B251-E1FA2F361311Q36860745-9C39E870-0E86-46F7-953B-E223E8FD2858Q36950743-0CDD7A25-FC63-409E-98A2-7119675D3823Q37070966-D4F756C2-6066-4815-90A1-63778DBB7543Q37089542-77BD5F6D-9BF4-4D1D-9F56-E8D5217ABEA8Q37229073-5BBCE872-EBCB-47F4-80EC-0940E25852D0Q37299863-E0A0DF99-C712-476E-85BF-5B64A8F7DAEAQ37321670-CD79192B-4D23-4791-93BD-A04BD0CC0849Q37685266-8288AAAE-2383-40BA-8A14-B808ED589B55Q38901515-ECED1346-0AF6-499C-9646-77EBABCB65D8Q40116139-42886FD5-06C4-4BED-BD5C-0F9A0CBCD2CCQ41980574-20A86223-6399-48C0-8A29-3E407F5E7E91Q42672019-D32541A6-DEEF-4852-84E2-19C8BB795697
P2860
Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
@ast
Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
@en
type
label
Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
@ast
Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
@en
prefLabel
Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
@ast
Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
@en
P1433
P1476
Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
@en
P304
P577
2005-12-01T00:00:00Z